| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 157,137,118 | 114,483,573 | 88,326,980 | | Cost of Revenue | 94,777,882 | 53,659,295 | 42,191,389 | | | Gross Profit | 62,359,236 | 60,824,278 | 46,135,590 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 26,930,012 | 24,289,870 | 12,885,126 | | Non Recurring | (1,818,347) |
-
| (36,793) | | Others | 13,878,260 | 9,134,288 | 7,405,088 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 23,369,310 | 27,400,121 | 25,882,170 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 175,013 | 154,100 | 274,348 | | Earnings Before Interest And Taxes | 24,174,986 | 28,513,510 | 25,946,783 | | Interest Expense | 434,672 | 492,875 | 412,804 | | Income Before Tax | 23,740,314 | 28,020,635 | 25,533,979 | | Income Tax Expense | 5,160,613 | 6,738,739 | 6,555,379 | | Minority Interest |
-
|
-
| (1,102,520) | | | | Net Income From Continuing Ops | 18,579,702 | 21,281,896 | 18,728,353 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 18,579,702 | 21,281,896 | 18,728,353 | | Preferred Stock And Other Adjustments |
-
| (8,845,281) | (8,204,928) | | | Net Income Applicable To Common Shares | $18,579,702 | $12,436,615 | $10,523,425 |
|
0.18% Nasdaq 
Income Statement
